139 related articles for article (PubMed ID: 8163500)
1. Identification of two cardiac glycosides as Na(+)-pump inhibitors in rat urine and diet.
Tamura M; Harris TM; Phillips D; Blair IA; Wang YF; Hellerqvist CG; Lam SK; Inagami T
J Biol Chem; 1994 Apr; 269(16):11972-9. PubMed ID: 8163500
[TBL] [Abstract][Full Text] [Related]
2. Na+,K+-ATPase inhibitors in rat urine: origins and physiological significance.
Tamura M; Landon EJ; Inagami T
Clin Exp Hypertens; 1998; 20(5-6):543-50. PubMed ID: 9682910
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of an endogenous Na+,K(+)-ATPase-specific inhibitor from pig urine.
Tamura M; Harris TM; Konishi F; Inagami T
Eur J Biochem; 1993 Jan; 211(1-2):317-27. PubMed ID: 8381085
[TBL] [Abstract][Full Text] [Related]
4. A novel endogenous sodium-pump inhibitor in pig urine: purification and comparison with the inhibitor purified from bovine adrenal glands.
Tamura M; Konishi F; Inagami T
J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S47-50. PubMed ID: 7508027
[TBL] [Abstract][Full Text] [Related]
5. Isolation of an endogenous Na-pump specific inhibitor from normal pig urine: characterization and comparison with the inhibitor purified from bovine adrenal glands.
Tamura M; Naruse M; Sakakibara M; Inagami T
Biochim Biophys Acta; 1993 May; 1157(1):15-22. PubMed ID: 8388731
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of a specific endogenous Na+,K+-ATPase inhibitor from bovine adrenal.
Tamura M; Lam TT; Inagami T
Biochemistry; 1988 Jun; 27(12):4244-53. PubMed ID: 2844224
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships for the hypertensinogenic activity of ouabain: role of the sugar and lactone ring.
Manunta P; Hamilton BP; Hamlyn JM
Hypertension; 2001 Feb; 37(2 Pt 2):472-7. PubMed ID: 11230321
[TBL] [Abstract][Full Text] [Related]
8. Effect of dietary cardiac glycosides on blood pressure regulation in rats.
Tamura M; Utsunomiya H; Nakamura M; Landon EJ
Can J Physiol Pharmacol; 2000 Jul; 78(7):548-56. PubMed ID: 10926161
[TBL] [Abstract][Full Text] [Related]
9. Cardiac glycosides induced toxicity in human cells expressing α1-, α2-, or α3-isoforms of Na-K-ATPase.
Cherniavsky Lev M; Karlish SJ; Garty H
Am J Physiol Cell Physiol; 2015 Jul; 309(2):C126-35. PubMed ID: 25994790
[TBL] [Abstract][Full Text] [Related]
10. Revisiting the binding kinetics and inhibitory potency of cardiac glycosides on Na
Noël F; Azalim P; do Monte FM; Quintas LEM; Katz A; Karlish SJD
J Pharmacol Toxicol Methods; 2018; 94(Pt 2):64-72. PubMed ID: 30244071
[TBL] [Abstract][Full Text] [Related]
11. Comparison of low-molecular-weight plasma and urine Na-K-ATPase inhibitors/hypertensive factors.
Gonick HC; Weiler EW; Prins BA; Purdy RE
J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S69-71. PubMed ID: 7508033
[TBL] [Abstract][Full Text] [Related]
12. Characterization of digitalis-like factors in human plasma. Interactions with NaK-ATPase and cross-reactivity with cardiac glycoside-specific antibodies.
Kelly RA; O'Hara DS; Canessa ML; Mitch WE; Smith TW
J Biol Chem; 1985 Sep; 260(21):11396-405. PubMed ID: 2995332
[TBL] [Abstract][Full Text] [Related]
13. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
[TBL] [Abstract][Full Text] [Related]
14. Endogenous sodium pump inhibitors in human urine. Further identification of inhibitors of Na-K-ATPase.
Kramer HJ; Krampitz G; Bäcker A; Michel H; Krampitz G; Meyer-Lehnert H
Am J Hypertens; 1995 Jul; 8(7):753-60. PubMed ID: 7546503
[TBL] [Abstract][Full Text] [Related]
15. Further biochemical characterization of an Na+ pump inhibitor purified from human urine.
Crabos M; Grichois ML; Guicheney P; Wainer IW; Cloix JF
Eur J Biochem; 1987 Jan; 162(1):129-35. PubMed ID: 3028785
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of human erythrocyte Na+/K+ ATPase by cardiac glycosides and by a mammalian digitalis like factor.
Balzan S; D'Urso G; Ghione S; Martinelli A; Montali U
Life Sci; 2000 Sep; 67(16):1921-8. PubMed ID: 11072868
[TBL] [Abstract][Full Text] [Related]
17. Bovine adrenals contain, in addition to ouabain, a second inhibitor of the sodium pump.
Schneider R; Wray V; Nimtz M; Lehmann WD; Kirch U; Antolovic R; Schoner W
J Biol Chem; 1998 Jan; 273(2):784-92. PubMed ID: 9422732
[TBL] [Abstract][Full Text] [Related]
18. High sensitivity of the Na+, K+-pump of human red blood cells to genins of cardiac glycosides.
Senn N; Lelièvre LG; Braquet P; Garay R
Br J Pharmacol; 1988 Apr; 93(4):803-10. PubMed ID: 3390651
[TBL] [Abstract][Full Text] [Related]
19. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia.
Lopatin DA; Ailamazian EK; Dmitrieva RI; Shpen VM; Fedorova OV; Doris PA; Bagrov AY
J Hypertens; 1999 Aug; 17(8):1179-87. PubMed ID: 10466474
[TBL] [Abstract][Full Text] [Related]
20. Ouabainlike factor in Milan hypertensive rats.
Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
Am J Physiol; 1992 Oct; 263(4 Pt 2):F739-48. PubMed ID: 1329560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
